Recombinant Urate Oxidase for the Prophylaxis or Treatment of Hyperuricemia in Patients With Leukemia or Lymphoma
Top Cited Papers
- 1 February 2001
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (3) , 697-704
- https://doi.org/10.1200/jco.2001.19.3.697
Abstract
PURPOSE: To improve the control of hyperuricemia in patients with leukemia or lymphoma, we tested a newly developed uricolytic agent, recombinant urate oxidase (SR29142; Rasburicase; Sanofi-Synthel...Keywords
This publication has 25 references indexed in Scilit:
- Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1998
- Development of a Two-Site Immunoassay of Recombinant Urate Oxidase (SR 29142) and Its Use for Determination of Pharmacokinetic Parameters in Rats and BaboonsJournal of Pharmaceutical Sciences, 1996
- Molecular evolution of the urate oxidase-encoding gene in hominoid primates: nonsense mutationsGene, 1991
- Renal dysfunction and hyperuricemia at presentation and relapse of acute lymphoblastic leukemiaMedical and Pediatric Oncology, 1990
- Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: Relationship to acute renal failureThe Journal of Pediatrics, 1986
- Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemiaThe Journal of Pediatrics, 1982
- Renal and Metabolic Complications of Undifferentiated and Lymphoblastic LymphomasMedicine, 1981
- Multiple uses of small computers in radiotherapyPhysics in Medicine & Biology, 1972
- Nephropathy, xanthinuria, and orotic aciduria complicating Burkitt's lymphoma treated with chemotherapy and allopurinolMetabolism, 1972
- Prevention and management of acute hyperuricemia in childhood leukemiaThe Journal of Pediatrics, 1968